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Abstract
Introduction: The aim of the study was to estimate the influence of nicotine on thyroid volume according to patients’ sex.
Material and methods: A group of 160 patients with thyroid disorders in their past medical history was examined. Patients were divided
into two groups: Group A contained 50 patients with goiter, where the volume of the thyroid was evaluated with use of US and 131I-SPECT;
group B contained 50 patients with goiter, where the volume of the thyroid was evaluated with use of US and 99mTc-SPECT. There were
two control groups: Group A’ contained 30 patients with normal volume of the thyroid gland shown by US and 131I-SPECT, and group B’
contained 30 patients with normal volume of the thyroid gland shown by US and 99mTc-SPECT. The patients from the examined and
control groups were divided into two subgroups — smokers and non-smokers.
US of the thyroid gland was made by means of an ALOKA SSD 500 device. SPECT was performed by means of a singke-headed gamma
camera by Diacam.
Results: The average volume of thyroid gland measured by 131I-SPECT and 99mTc-SPECT was significantly larger according to US in the
examined and control groups in smokers and non-smokers. We did not show statistically significant correlations between levels of iodine
uptake and volumes of goiter evaluated by US examination together with 131I scintigraphy.
Conclusions: Significant differences in average values of thyroid volume between smokers and non-smokers were not observed, which
might suggest a lack of goitrogenic activity of tobacco smoke or indicates a potential goitrogenic influence not significant enough in the
examined group. (Pol J Endocrinol 2009; 60 (6): 437–442)
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Streszczenie
Wstęp: Celem tego badania było oszacowanie wpływu nikotyny na objętość tarczycy w zależności od płci pacjentów.
Materiał i metody: Przebadano grupę 160 pacjentów z chorobami tarczycy w wywiadzie. Pacjentów podzielono na dwie grupy. Grupa A
składała się z 50 pacjentów z wolem, u których objętość tarczycy oceniano za pomocą USG i 131I-SPECT. Grupa B składała się z 50 pacjen-
tów z wolem, u których objętość tarczycy oceniano za pomocą USG i 99mTc-SPECT. Stworzono dwie grupy kontrolne. Grupa A’ składała się
z 30 pacjentów z prawidłową objętością tarczycy w ocenie USG i 131I-SPECT i grupa B’ składająca się z 30 pacjentów z prawidłową objęto-
ścią tarczycy w ocenie USG i 99mTc-SPECT. Pacjentów z grup badanej i kontrolnej podzielono na 2 podgrupy — palaczy i osoby niepalące.
Badania ultrasonograficzne tarczycy wykonywano za pomocą aparatu ALOKA SSD 500. Badanie SPECT przeprowadzono z zastosowa-
niem gammakamery Diacam.
Wyniki: Średnia objętość tarczycy oszacowana za pomocą 131I-SPECT o 99mTc-SPECT była istotnie większa w porównaniu z objętością
oszacowaną w badaniu USG w grupach badanych i kontrolnych, palaczy i osób niepalących. Autorzy nie wykazali istnienia znamiennej
korelacji pomiędzy poziomem wychwytu jodu a objętością wola ocenianą za pomocą badania USG połączonym ze scyntygrafią 131I.
Wnioski: Nie zaobserwowano istotnych różnic dotyczących średnich objętości tarczycy pomiędzy palaczami a osobami niepalącymi, co
może sugerować brak działania wolotwórczego dymu tytoniowego lub wskazywać na potencjalne działanie wolotwórcze w grupie bada-
nej, które nie było wystarczające istotne. (Endokrynol Pol 2009; 60 (6): 437–442)
Słowa kluczowe: wole, tarczyca, USG, SPECT
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Enlargement of the thyroid glands is called goiter (vo-
lume above 18 ml in females and above 25 ml in males).
The cause of goiter is most often long-term deficiency
of iodine in the diet, but another etiopathogenesis might
also occur, for example autoimmunological background.
Certain periods of life also predispose to goiter (for exam-
ple puberty) and certain states (for example pregnancy
and state of physiologic lactation). Increased demand for
thyroid hormones is observed during these times.
Goitryne (1,5-vinyl-2-tioxalidone) located in some
vegetables, for example Brussels sprouts, radishes, spi-
nach, and soya beans, is found in the group of goitro-
genic factors.
Environmental pollution also has some influence on
goiter occurrence. Different inorganic compounds (tio-
cyianides, chlorides, nitrates) and organic compounds
(phenols, carbohydrates, and others) possess goitroge-
nic characteristics. Ingredients of tobacco smoke like
derivatives of resorcinol, flavonoids, hydroxypyridines,
and particularly tiocyianides can have goitrogenic pro-
perties through competitive inhibition of iodine trans-
port to thyroid cells and iodine organification reactions.
The aim of our study was the evaluation of goiter vo-
lume by ultrasonographic and radioisotopic methods to-
gether with the evaluation of nicotine (smoking) influen-
ce on thyroid volume with regard to the sex of the exami-
ned persons, and the relationship between iodine uptake
and thyroid volume in smokers and non-smokers.
Material and methods
One hundred and sixty patients with Graves’ disease
in anamnesis were included in the study and were re-
ferred for diagnostic examinations from the outpatient
clinic of endocrinology and the Department of Endo-
crinology and Diabetology of Collegium Medicum in Byd-
goszcz. The patients were divided into two groups:
A and B. Group A consisted of 50 patients (39 females,
11 males) with goiter, where thyroid volume was com-
pared by US and scintigraphy (SPECT) with use of 131I.
Group B consisted of 50 patients (43 females, 7 males)
with goiter, where thyroid volume was compared by
US and scintigraphy (SPECT) with use of 99mTc.
There were two control groups, A’ and B’. Control
group A’ consisted of 30 patients (21 females, 9 males)
with normal volume of thyroid gland in US and scinti-
graphy (SPECT) with use of 131I. Control group B’ consi-
sted of 30 patients (23 females, 7 males) with regular
volume of thyroid gland in US and scintigraphy
(SPECT) with use of 99mTc.
 Subjects from the examined groups (A and B) and
the control groups (A’ and B’) were divided in two sub-
groups — smokers (minimum 5 cigarettes per day) and
non-smokers.
We had the approval of the Institutional Review
Board and Local Committee of Ethics for our study.
All patients were examined by US and scintigraphy
(SPECT) of the thyroid gland, with use of 99mTc or 131I,
and were evaluated according to iodine uptake. Ultra-
sonography was carried out with an ALOKA SSD 500,
working in real time with a linear head of 7.5 MHz fre-
quency.
Single positron emission computed tomography
(SPECT) of the thyroid gland was performed with  a sin-
gle-headed gamma camera by Diacam, using a low-ener-
gy collimator of high resolution for SPECT examination
with use of 99mTc (140,5 keV), and a high-energy collima-
tor for SPECT examination with use of 131I (364 keV).
Results
The patients from examined group A and control gro-
up A’ were divided into two subgroups — smokers and
non-smokers.
The thyroid volume measured in the 131I-SPECT exa-
mination was significantly larger in comparison to the
US examination in the examined and control groups in
smokers and in non-smokers (Fig. 1).
Figure 1. Comparison of thyroid volume measured by means of
US and 131I-SPECT in smokers and non-smokers (females and
males)
Rycina 1. Porównanie objętości tarczycy mierzonej za pomocą
USG i badania 131I-SPECT u osób palących i niepalących (kobiety
i mężczyźni)
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The results of measurements of thyroid glands in
the US examination in smokers and non-smokers toge-
ther with the 131I-SPECT examination in smokers and
non-smokers are presented in Table I.
Statistically significant correlations between the le-
vel of iodine uptake and goiter volume evaluated by
US examination and scintigraphy (SPECT) with use of
131I (Table II) were not observed.
The division of goiter volume and 131I uptake con-
cerning smokers and non-smokers is presented in Ta-
bles III–V.
Patients from examined group B and control group
B’ were divided into two subgroups – smokers and non-
smokers.
The thyroid volume measured in the 99mTc-SPECT
examination was significantly larger compared to that
Table III. Small goiter: F = 18–40 ml; M = 25–40 ml
Tabela III. Wole małe: K = 18–40 ml; M = 25–40 ml
Small goiter Smokers Non-smokers p
Females 31.6% 48.65% < 0.001
(n = 23) (n = 11)  (n = 12)
Males 30.6% 48.03% NS
(n = 5) (n = 1) (n = 4)
F+M 31.51% 48.5% < 0.001
(n = 28) (n = 12)  (n = 17)
Table IV. Large goiter: F i M = 40–100 ml
Tabela IV. Wole duże: K i M = 40–100 ml
Large goiter Smokers Non-smokers p
Females 46.64% 53.27% NS
(n = 14) (n = 3)  (n = 11)
Males 48.46% 37.35% NS
(n = 5) (n = 3)  (n = 2)
F+M 47.55% 50.82% NS
(n = 19)  (n = 6)  (n = 13)
Table I. Comparison of thyroid volume with US in smokers and non-smokers together with 131I-SPECT examination in smokers
and non-smokers
Tabela I. Porównanie objętości tarczycy za pomocą badania ultrasonograficznego u osób palących i niepalących z badaniem
131I-SPECT u osób palących i niepalących
Sex Smokers Non-smokers p
n Average volume±SD n Average volume±SD
Examined group US F+M 19 39.48 ± 26.16 31 47.66 ± 33.67 NS
F 15 37.36 ± 27.4 24 47.61 ± 35.6 NS
M 4 47.43 ± 18.83 7 47.84 ± 26 NS
SPECT 131I F+M 19 44.96 ± 24.87 31 52.56 ± 31.01 NS
F 15 42.95 ± 26.06 24 51.99 ± 32.42 NS
M 4 52.47 ± 17.88 7 54.53 ± 25.47 NS
Control group US F+M 11 12.69 ± 3.61 19 14.49 ± 4.49 NS
F 7 10.9 ± 1.76 14 13.99 ± 2.67 < 0,01
M 4 15.83 ± 3.87 5 15.9 ± 4.83 NS
SPECT 131I F+M 11 15.66 ± 3.38 19 16.5 ± 2.75 NS
F 7 13.63 ± 2.56 14 15.84 ± 2.22 NS
M 4 19.19 ± 4.74 5 18.27 ± 3.22 NS
Table II. Correlation of goiter volume evaluated by US and
131I-SPECT with iodine uptake level in examined and control
groups
Tabela II. Korelacja pomiędzy objętością wola oceniana za
pomocą badania ultrasonograficznego i 131I-SPECT a poziomem
jodochwytności w grupach badanej i kontrolnej
Parameter Sex Examined group Control group
r p r p
US F + M 0.144 NS 0.333 NS
F 0.209 NS 0.303 NS
M –0.253 NS 0.576 NS
SPECT 131I F + M 0.171 NS 0.203 NS
F 0.236 NS 0.24 NS
M –0.189 NS 0.382 NS
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measured by US in the examined and control groups in
smokers and non-smokers (Fig. 2).
Results of measurements of thyroid volume by US
in smokers and non-smokers together with 99mTc-SPECT
examination in smokers and non-smokers are shown
in Table VI.
Discussion
Ultrasonography is the most frequently used method
to evaluate thyroid volume in routine clinical examina-
tions. This examination has many advantages: the me-
thod is available, inexpensive, repeatable, and non-inva-
sive [1–3]. The US method could be performed in every
patient, in certain circumstances, although, for example
in cases of retrosternal goiter, other methods of imaging
including scintigraphy are necessarily required.
There are numerous reports in scientific papers ava-
ilable in which the use of scintigraphy, especially SPECT,
is considered valuable in thyroid size evaluation. Zaidi [4]
concludes in his study that single photon emission com-
puted tomography is a much better and much more
sensitive examination of thyroid gland than planar scin-
tigraphy [3].
In the aforementioned study, thyroid volume was
compared with the use of US and scintigraphy (SPECT)
with 131I in the first group of patients (n = 50) and in the
control group (n = 30), and 99mTc in the second group
of patients (n = 50) and in the control group (n = 30).
Figure 2. Comparison of thyroid volume measured with US and
99mTc-SPECT in smokers and non-smokers (females and males)
Rycina 2. Porównanie objętości tarczycy mierzonej za pomocą
USG i badania 99mTc-SPECT u osób palących i niepalących (kobiety
i mężczyźni)
Table VI. Comparison of thyroid volume with US in smokers and non-smokers together with 99mTc-SPECT examination in
smokers and non-smokers
Tabela VI. Porównanie objętości tarczycy za pomocą badania ultrasonograficznego u osób palących i niepalących z badaniem
99mTc-SPECT u osób palących i niepalących
Sex Smokers Non-smokers p
n Average volume ± SD n Average volume ± SD
Examined group US F + M 15 29.49 ± 9.63 35 29.98 ± 11.03 NS
F 12 29.83 ± 10.72 31 29.16 ± 10.99 NS
M 3 28.11 ± 1.26 4 36.36 ± 9.11 NS
SPECT 99mTc F + M 15 31.85 ± 8.56 35 33.89 ± 11.2 NS
F 12 32.12 ± 9.5 31 32.8 ± 10.6 NS
M 3 30.76 ± 1.96 4 42.28 ± 12.1 NS
Control group US F + M 10 16.11 ± 4.92 20 15.95 ± 3.55 NS
F 5 11.9 ± 3.54 18 15.12 ± 2.66 NS
M 5 20.32 ± 0.75 2 23.44 ± 0.31 <0,001
SPECT 99mTc F + M 10 19.22 ± 4.62 20 17.66 ± 2.78 NS
F 5 15.05 ± 2.71 18 16.92 ± 1.75 NS
M 5 23.39 ± 0.78 2 24.34 ± 0.22 NS
Table V. Enormous goiter: F and M > 100 ml
Tabela V. Wole olbrzymie: K i M > 100 ml
Enormous goiter Smokers Non-smokers p
Females (n = 2) 21.7% 62.3% NS
Males (n = 1) – 30.3% –
F + M (n = 3) 21.7% 46.3% NS
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In both examined groups, similar relativeness was obse-
rved. The average volume of goiter was 44.55 ml in US
and 49.67 ml in SPECT, in the first group of patients (131I).
However, thyroid volume was 13.83 ml v. 16.19 ml in the
control group.
In the second group of patients, (99mTc) differences
of average measurements of goiter volume between US
and SPECT were 3.44 ml (29.83 ml v. 33.27 ml); however,
in the control group it was 2.18 ml (16 ml v. 18.18 ml).
The differences of measurements reached significance
levels.
In the past 20 years a number of studies have cove-
red the influence of smoking on the thyroid gland. The
results of many publications indicate a potential, com-
plex influence of nicotine on the size and activity of the
thyroid gland. Smoking might have a stimulating in-
fluence on the thyroid gland in healthy people, but the
influence of nicotine in patients with subclinical or evi-
dent hypothyroidism might be inhibiting.
Evaluation of the influence of smoking on goiter
development is one of the analyzed issues. Various opi-
nions on the possible goitrogenic activity of tobacco
smoke are concluded in available publications.
Most of the recent studies indicate that smoking
might influence an increase in thyroid volume and go-
iter development [5–8]. Smoking might even be an in-
dependent risk factor of goiter development, according
to some scientists [9, 10]. More frequently, goiter, eva-
luated by physical examination as with US, was noted
in smokers in comparison to non-smokers in various
published research [7, 9, 11–14]. The goitrogenic influ-
ence of smoking tobacco was confirmed by Christen-
sen et al. in their research [11]. They observed goiter in
15% of examined smokers in palpation. However, go-
iter was observed only in 9% of non-smokers. Larger
volumes of thyroid and increased frequency of goiter
among smokers were observed especially in areas with
iodine deficit. The aforementioned observations suggest
synergic impact of smoking and insufficient iodine inta-
ke. The possible influence of nicotine on changes in the
echogenicity of the thyroid gland was indicated in seve-
ral scientific reports, because more frequent multinodu-
lar goiter was observed among smokers [15, 16].
The goitrogenic mechanism of cigarettes is not yet
explained. It is assumed that the ingredients of tobacco
smoke, such as derivatives of resorcinol, flavonoids,
hydroxypyridines, and especially tiocyianides, might
inhibit iodine transport to thyroid cells and the reac-
tion of iodine organification. Such substances might also
enable iodine to go out of the thyroid gland [12, 17, 18].
On the basis of experiments, tiocyianides were observed
to be the most goitrogenic of all ingredients of tobacco
smoke [18]. The results of some research indicate possi-
ble goitrogenic activity of tiocyianides, in which a positi-
ve correlation between tiocyianides concentration in blo-
od serum and volume of thyroid gland was shown [6].
Some scientists also suggest a different, indirect go-
itrogenic mechanism of nicotine, like possible activa-
tion of the sympathetic nervous system [12, 13] and the
stimulation of thyroid hormones output related to that.
On the other hand, there are some reports indica-
ting a lack of influence of smoking on the volume of
the thyroid gland [19–21]. Gomez et al. [19] carried out
a study on 268 patients (134 females and 134 males)
without thyroid disease in anamnesis, in which they
did not observe any influence of smoking cigarettes on
thyroid volume. In addition, Fatma et al. [20], after the
examination of 500 patients, did not conclude statisti-
cally essential differences in thyroid volume in smokers
and non-smokers. The more common abnormalities of
the echogenic structure of the thyroid gland in smokers
were also not observed in several other studies [20, 22].
Mentioned relativeness was observed in areas of
sufficient iodine intake, where the research was carried
out by Gomez [19] and Fatma [20].
In the aforementioned study, statistically significant
differences in thyroid volume were not observed be-
tween smokers and non-smokers, in the examined and
control groups. The results were obtained in Poland, in
the Kujawsko-Pomorskie region, where this research
study was carried out. This region is connected to the
Wielkopolskie region, where despite iodine prophyla-
xis introduced in 1996, permanent iodine deficit is ob-
served [23].
The results obtained by Georgiadis et al. [22] were
notable because the authors proved goitrogenic activi-
ty of smoking tobacco only in patients with positive fa-
mily anamnesis regarding goiter. The primarily obse-
rved differences in thyroid volume between smokers
and non-smokers disappeared after excluding persons
with first level relatives having goiter of analysis.
In the aforementioned study, no significant correla-
tion between thyroid volume and iodine uptake was
observed in patients from the examined and control
groups. The size of thyroid gland did not influence the
level of iodine uptake significantly.
No scientific papers evaluating the correlation be-
tween thyroid volume and iodine uptake in areas of
satisfactory iodine intake were found in the literature.
The influence of nicotine on iodine uptake in pa-
tients with goiter was also evaluated in this study. Lo-
wer than average radioiodine uptake was observed in
the group of patients with small goiter (£ 40 ml) and
cigarette smoking, in comparison with the non-smokers
(31.51% v. 48.5%; p < 0,001).
The obtained results might be explained by the pro-
bable inhibiting influence of cigarette smoking on iodi-
ne uptake by thyroid gland cells, as suggested by au-
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thors of some recently published research [12, 18].
A vital role in this process is connected to the tiocyianides
present in tobacco smoke [18]. Antithyroid activity of other
ingredients of tobacco smoke cannot be excluded.
Conclusions
1. Measurement of thyroid volume in the examined
group and the control group was significantly in-
creased in SPECT examination with use of 131I and
99mTc, according to US examination.
2. Significant differences in average values of thyroid
volume between smokers and non-smokers were
not observed, which might suggest lack of goitroge-
nic activity of tobacco smoke or indicate that the
potential goitrogenic influence was not significant
enough in the examined groups.
3. The size of thyroid gland did not significantly influ-
ence the level of iodine uptake. Lower than average
uptake of iodine 131I was observed in smokers with
small goiter (£ 40 ml) in comparison with non-smo-
kers, which might a suggest probable inhibiting in-
fluence of tobacco smoke on iodine uptake by thy-
roid gland cells.
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